The importance of extracellular vesicles in the pathogenesis of virtually all human diseases and as treasure chests of disease biomarkers has recently been appreciated, which holds an enormous untapped potential for medical and biotechnological exploitation. EVEXyS is committed to being a leader in capitalizing on the diagnostic and therapeutic opportunities created by this remarkable scientific revolution.
Key discoveries made by EVEXyS scientists related to identification of disease-specific plasma extracellular vesicle (pEV) biomarker patterns and pEV isolation methods place us in an excellent position for spearheading this exciting development.
The products EVEXyS is offering and developing will change the way we predict, diagnose, and monitor human diseases. Hence the EVEXyS test systems offer entirely new visions for population-wide diagnostic screening, optimizing personalized medicine, as well as cutting health care costs.